| Literature DB >> 33589104 |
Sarah F Keller1, Brian F Mandell2.
Abstract
Gout is the most common inflammatory arthritis in the United States. Gouty arthritis is associated with significant morbidity and mortality and is caused by hyperuricemia. Gout is effectively managed and potentially cured by decreasing the overall urate burden with serum urate-lowering therapy. When serum urate is maintained at less than 6.0 mg/dL urate deposition is resolved and gout can be cured. Unfortunately, owing to a lack of physician monitoring and dose escalation the majority of patients do not achieve these urate levels.Entities:
Keywords: Gout; Hyperuricemia; Inflammatory arthritis; Treat-to-target; Uric acid
Mesh:
Substances:
Year: 2021 PMID: 33589104 DOI: 10.1016/j.mcna.2020.09.013
Source DB: PubMed Journal: Med Clin North Am ISSN: 0025-7125 Impact factor: 5.456